A 61-year-old man with asymptomatic, bilateral lung masses.
Rehman
Tayyab
T
Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Ali
Juzar
J
Lopez
Fred A
FA
D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D003424:Crohn Disease; D003453:Cryptococcosis / Q000139:chemically induced / Q000175:diagnosis* / Q000188:drug therapy; D003455:Cryptococcus neoformans / Q000302:isolation & purification*; D004502:Education, Medical, Continuing; D006801:Humans; D000069285:Infliximab; D008168:Lung / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology* / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab